Treatment of spasticity with botulinum toxin: A double‐blind study
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
We studied the effect of botulinum‐A toxin on spasticity of the leg adductors in 9 patients who were either chair‐bound or bed‐bound with chronic stable multiple sclerosis. We injected botulinum toxin (400 mouse units) or placebo into the adductor muscles in a randomized, crossover, double‐blind design. Two physicians, who were unaware of the treatment order, used an objective rating scale and independently assessed the patients; interobserver correlation was excellent (r = 0.93‐0.81). We found that botulinum toxin produced a significant reduction in spasticity (p = 0.009) and a significant improvement in the ease of nursing care(p = 0.009). There were no adverse effects during this shortterm trial. This is the first demonstration of the beneficial effect of botulinum toxin on focal spastic muscle contractions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
Ashworth, B. (1964) · PubMed · Cited by 1,475
DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS
Tsui, J. C., Jon Stoessl, A., Eisen, A., Calne, S., & Calne, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92070-2 · Cited by 810
Self-citationIntrathecal Baclofen for Severe Spinal Spasticity
Penn, R. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., & Kroin, J. S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202303 · Cited by 754
PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90197-7 · Cited by 397
Botulinum Toxin: Mechanism of Presynaptic Blockade
Kao, I., Drachman, D. B., & Price, D. L. (1976) · Science · doi:10.1126/science.785600 · Cited by 270
Botulinum toxin in spasmodic torticollis.
Stell, R., Thompson, P. D., & Marsden, C. D. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.7.920 · Cited by 250
Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia
Ludlow, C. L., Naunton, R. F., Sectary, S. E., Schulz, G. M., & Hallett, M. (1988) · Neurology · doi:10.1212/wnl.38.8.1220 · Cited by 209
Anatomic Guide for the Electromyographer
Tichauer, E. R. (1977) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197712000-00042 · Cited by 193
Cited by
Therapeutic Uses of Botulinum Toxin
Oates, J. A., Wood, A. J. J., Jankovic, J., & Brin, M. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241707 · Cited by 801
Simpson, D. M., Blitzer, A., Brashear, A., Comella, C., Dubinsky, R., Hallett, M., Jankovic, J., Karp, B., Ludlow, C. L., Miyasaki, J. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311389.26145.95 · Cited by 618
National Clinical Guidelines for Stroke.
Robinson, T. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.906.286h · Cited by 608
Botulinum Toxin Type A as a Migraine Preventive Treatment
Silberstein, S., Mathew, N., Saper, J., Jenkins, S., & for the BOTOX Migraine Clinical Research Group (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00066.x · Cited by 541
Simpson, D. M., Alexander, D. N., O'Brien, C. F., Tagliati, M., Aswad, A. S., Leon, J. M., Gibson, J., Mordaunt, J. M., & Monaghan, E. P. (1996) · Neurology · doi:10.1212/wnl.46.5.1306 · Cited by 418
European consensus table on the use of botulinum toxin type A in adult spasticity
Wissel, J., Ward, A., Erztgaard, P., Bensmail, D., Hecht, M., Lejeune, T., & Schnider, P. (2009) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0303 · Cited by 372
BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY
Cosgrove, A. P., Corry, I. S., & Graham, H. K. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11864.x · Cited by 354
Turner-Stokes, L., & Jackson, D. (2002) · Clinical Rehabilitation · doi:10.1191/0269215502cr491oa · Cited by 353
Spasticity-assessment: a review
Biering-Sørensen, F., Nielsen, J. B., & Klinge, K. (2006) · Spinal Cord · doi:10.1038/sj.sc.3101928 · Cited by 342
Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences
Göschel, H., Wohlfarth, K., Frevert, J., Dengler, R., & Bigalke, H. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6580 · Cited by 315
Anti-spasticity agents for multiple sclerosis
Shakespeare, D., Boggild, M., & Young, C. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001332 · Cited by 271
Treatments for spasticity and pain in multiple sclerosis: a systematic review
Beard, S., Hunn, A., & Wight, J. (2003) · Health Technology Assessment · doi:10.3310/hta7400 · Cited by 266
Sutherland, D. H., Kaufman, K. R., Wyatt, M. P., Chambers, H. G., & Mubarak, S. J. (1999) · Gait & Posture · doi:10.1016/s0966-6362(99)00012-0 · Cited by 218
“Previous reports have included randomized, doubleblind studies of the use of botulinum A toxin in patients with spasmodic torticollis [8,11], upper extremity spasticity in stroke [12], upper extremity spasticity in cerebral palsy [13], adductor spasticity in multiple sclerosis [14], and dynamic equinus in cerebral pal…”
BackgroundUse of botulinum toxin in stroke patients with severe upper limb spasticity.
Bhakta, B. B., Cozens, J. A., Bamford, J. M., & Chamberlain, M. A. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.1.30 · Cited by 190
Management of Spasticity Associated Pain with Botulinum Toxin A
Wissel, J., Müller, J., Dressnandt, J., Heinen, F., Naumann, M., Topka, H., & Poewe, W. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00146-9 · Cited by 185
“9 [4–12] weeks following baseline assessment and injection.”
BackgroundBOTOX and Physical Therapy in the Treatment of Piriformis Syndrome
Fishman, L. M., Anderson, C., & Rosner, B. (2002) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-200212000-00009 · Cited by 182
Drugs Used to Treat Spasticity
Kita, M., & Goodkin, D. E. (2000) · Drugs · doi:10.2165/00003495-200059030-00006 · Cited by 172
Mauritz, K. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.0090s1023.x · Cited by 167
Managing the symptoms of multiple sclerosis: A multimodal approach
Crayton, H. J., & Rossman, H. S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.04.005 · Cited by 159
Metadata
- Authors
- Snow, B. J., Tsui, J. K. C., Bhatt, M. H., Varelas, M., Hashimoto, S. A., & Calne, D. B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1990-10
- Volume
- 28
- Issue
- 4
- Pages
- 512-515
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982567739
- Cited by
- 414
- References
- 12
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.